Mystic Ventures logo

Mystic Ventures

North America, California, United States, Los Angeles

Description

Mystic Ventures is an early-stage venture fund making targeted investments in the blossoming PsyMed space.

Investor Profile

Mystic Ventures has made 27 investments, with 1 in the past 12 months and 15% as lead.

Stage Focus

  • Seed (56%)
  • Pre Seed (11%)
  • Series A (11%)
  • Series Unknown (11%)
  • Undisclosed (7%)
  • Post Ipo Equity (4%)

Country Focus

  • United States (70%)
  • Canada (7%)
  • Australia (4%)
  • Brazil (4%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Therapeutics
  • Wellness
  • Life Science
  • Clinical Trials
  • Fitness
  • Psychology
  • Mental Health
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Mystic Ventures frequently co-invest with?

Gaingels
North America, Vermont, United States, Burlington
Co-Investments: 1
SY
North America, Connecticut, United States, New Haven
Co-Investments: 1
MBX Capital
North America, New York, United States, New York
Co-Investments: 1
Tabula Rasa Ventures
North America, New York, United States, New York
Co-Investments: 2
Beni VC
North America, Florida, United States, Miami
Co-Investments: 1
PsyMed Ventures
North America, California, United States, San Francisco
Co-Investments: 2
UC
Europe, England, United Kingdom, London
Co-Investments: 1
Village Global
North America, California, United States, Covina
Co-Investments: 1
M8 Ventures
Oceania, New South Wales, Australia, Sydney
Co-Investments: 1
Empath Ventures
North America, California, United States, Los Angeles
Co-Investments: 2

Which angels does Mystic Ventures often collaborate with?

VP
North America, Massachusetts, United States, Boston
Shared Deals: 1
A(
North America, Massachusetts, United States, Boston
Shared Deals: 1
AI
Europe, Cyprus
Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by Mystic Ventures?

Psylo

Sydney, New South Wales, Australia

Psylo is a drug development company that focuses on next-generation psychedelics.

Biotechnology
SeedJun 3, 2024
Amount Raised: $8,000,000

Proprietary Medical Psilocybin Delivery Systems

BiotechnologyClinical TrialsLife ScienceMedicalTherapeutics
Series UnknownAug 1, 2023
Awakn Life Sciences

Toronto, Ontario, Canada

Awakn Life Sciences is an ecosystem for psychedelic-based treatments.

BiotechnologyHealth CareLife Science
Post Ipo EquityApr 26, 2023
Amount Raised: $1,967,448
Sama Therapeutics

Boston, Massachusetts, United States

Precision Neuropsychiatry

Health Care
Pre SeedApr 1, 2023
Heading Health

Austin, Texas, United States

Heading Health is a technology-enabled mental health platform improving access to affordable care.

Health CareMedicalMental HealthmHealthWellness
Series UnknownApr 1, 2023
2A Biosciences

Santa Monica, California, United States

2A Biosciences is a pharmaceutical company that develops drugs with small molecules focusing on inflammation using 2A agonists.

BiopharmaBiotechnologyHealth CareLife Science
SeedApr 1, 2023
DopaGE

Venice, California, United States

DopaGE is standardizing illicit drug education via gamified courses to measurably reduce death and suffering related to substance use.

B2BEducationHealth Care
Pre SeedMar 30, 2023
Nucleus

Fort Lauderdale, Florida, United States

Nucleus is a venture capital firm that supports emerging companies within the psychedelic ecosystem.

CommunitiesConsultingMedicalVenture Capital
SeedJan 1, 2023
Enthea

Newton, Massachusetts, United States

Enthea provides employee benefit plans that offer access to save and affordable psychedelic-assisted therapy.

Health CareInsuranceMedicalPsychology
SeedDec 6, 2022

Proprietary Medical Psilocybin Delivery Systems

BiotechnologyClinical TrialsLife ScienceMedicalTherapeutics
SeedDec 1, 2022